Skip to main content
. 2020 Sep 13;6(3):151–159. doi: 10.1016/j.afos.2020.08.003

Table 1.

Quality assessment of studies included in this systematic review.

Study [Reference] Study design Score awarded/Full score
Percent (%)
Selection Comparability Exposure/Outcome Total
Biver E [9] Cross-sectional 2/4 2/2 2/2 6/8 75.0
Center JR [11] Prospective cohort 4/4 0/2 3/3 7/9 77.78
Ettinger B [5] Prospective cohort 4/4 2/2 2/3 8/9 88.89
Gehlbach S [18] Prospective cohort 3/4 1/2 2/3 6/9 66.67
Gnudi S [25] Prospective cohort 3/4 1/2 2/3 6/9 66.67
Gnudi S [14] Cross-sectional 3/4 0/2 2/2 5/8 62.5
Greenfield DM [20] Cross-sectional 3/4 2/2 2/2 7/8 87.5
Ho PY [27] Case control 3/4 1/2 1/3 5/9 55.56
Ingle BM [19] Cross sectional 4/4 1/2 2/2 7/8 87.5
Lauritzen JB [23] Prospective cohort 3/4 2/2 1/3 5/9 55.56
Lee DO [26] Case-control 3/4 1/2 2/2 6/8 75.0
Morin SN [17] Retrospective cohort 4/4 2/2 2/3 8/9 88.89
Pritchard JM [22] Prospective cohort 4/4 2/2 1/3 7/9 77.78
Robinson CM [8] Prospective cohort 4/4 2/2 1/3 7/9 77.78
Schuit SC [13] Prospective cohort 3/4 1/2 2/3 6/9 66.67
Seeley DG [24] Prospective cohort 4/4 2/2 2/3 8/9 88.89
Stein EM [12] Cross-sectional 3/4 0/2 2/2 5/8 62.5
Stone K [10] Prospective cohort 3/4 1/2 3/3 7/9 77.78
Taylor AJ [21] Retrospective cohort 3/4 2/2 1/3 6/9 66.67